Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MORPHEUS I/IIa: Morphine for Early Non-Invasive Ventilation Failure in Acute COPD Exacerbation
2024-516085-11-00Phase 2Authorised
- Sponsor
- CHU Grenoble Alpes
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of morphine in chronic obstructive pulmonary disease (COPD), sponsored by CHU Grenoble Alpes. Planned start Oct 2024; status: authorised.
02
Drugs
morphine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2024-516085-11-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516085-11-00.